(Q41412898)

30 September 2017

title

MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression (English)

1 reference

30 September 2017

1 reference

Honglin Zhu

1

1 reference

30 September 2017

Hui Luo

2

1 reference

30 September 2017

Yisha Li

3

1 reference

30 September 2017

Yaou Zhou

4

1 reference

30 September 2017

Ying Jiang

5

1 reference

30 September 2017

Jin Chai

6

1 reference

30 September 2017

Xianzhong Xiao

7

1 reference

30 September 2017

Yunhui You

8

1 reference

30 September 2017

Xiaoxia Zuo

9

1 reference

30 September 2017

publication date

9 May 2013

1 reference

Journal of Clinical Immunology

30 September 2017

published in

1 reference

30 September 2017

volume

33

1 reference

30 September 2017

issue

6

1 reference

30 September 2017

page(s)

1100-1109

1 reference

Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Transforming growth factor beta as a therapeutic target in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Systemic sclerosis: a prototypic multisystem fibrotic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Deficient Smad7 expression: a putative molecular defect in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Small non-coding RNAs in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

MicroRNAs and the regulation of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

MicroRNA array analysis of microRNAs related to systemic scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β(1) signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

MicroRNA-29, a key regulator of collagen expression in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Identification of a microRNA signature in renal fibrosis: role of miR-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Targeting microRNAs with small molecules: from dream to reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Proteasome inhibition induces hepatic stellate cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9896-Z

The widespread regulation of microRNA biogenesis, function and decay

21 January 2018

1 reference

12 December 2020

Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor kappaB.

1 reference

12 December 2020

On pediatric delirium and the use of the Pediatric Confusion Assessment Method for the Intensive Care Unit

1 reference

12 December 2020

Circulating miR-29a levels in patients with scleroderma spectrum disorder

1 reference

12 December 2020

Smad7: a new key player in TGF-beta-associated disease

1 reference

12 December 2020

Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis

1 reference

12 December 2020

10.1007/S10875-013-9896-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

30 September 2017

1009461109

0 references

1 reference